Results 151 to 160 of about 46,290 (201)

Impact of 2017 American Society of Clinical Oncology Guidelines on Postanthracycline Cardiac Surveillance Practices. [PDF]

JACC Adv
Zheng C, Spetko N, Liang L, Song Y, Hoeger CW, Gong J, Leukam M, Schlam I, Upshaw JN, Strom JB.   +9 more
europepmc   +1 more source

The mitigatory capabilities of exercise on breast cancer chemotherapy-induced cardiotoxicity. [PDF]

Front Cell Dev Biol
Qian CY, Fan J, Guo JY, Li N, Liu XQ, Liu X, Zeng XY, Huang CF, Li C, Liu HD, Liu JJ.   +10 more
europepmc   +1 more source

Chemotherapy-Free Achievement of Minimal Residual Disease in a Jehovah's Witness Patient With Ph-Negative B-ALL. [PDF]

Am J Case Rep
Koilpillai S, Altaf R, El Barche Palmera A, Hassanein H, Carlan SJ.   +4 more
europepmc   +1 more source

Various anthracyclines exhibit differential cytotoxic effects related to CBR1-induced resistance in lung cancer cells. [PDF]

Med Oncol
Piska K, Koczurkiewicz-Adamczyk P, Kochanowski P, Bobis-Wozowicz S, Władyka B, Pękala E.   +5 more
europepmc   +1 more source

Adipocytes Impair Mitoxantrone Cytotoxicity Against Acute Lymphoblastic Leukemia. [PDF]

EJHaem
Cohen M, Orgel E, Nevarez-Mejia J, Chen T, Neely M, Louie S, Mittelman SD.   +6 more
europepmc   +1 more source

Atorvastatin and left atrial function during anthracycline-based chemotherapy. [PDF]

J Cardiovasc Magn Reson
Juhasz V, Drobni ZD, Quinaglia T, Gilman HK, Suero-Abreu GA, Ghamari A, Heemelaar JC, Neuberg DS, Han Y, Ky B, Kwong RY, Januzzi JL, Asnani A, Mousavi N, Redd RA, Jerosch-Herold M, Scherrer-Crosbie M, Neilan TG.   +17 more
europepmc   +1 more source

Air Pollution and Cardiac Remodeling and Function in Patients With Breast Cancer.

JAMA Netw Open
Jung W, Ko K, Smith AM, Huang A, Xia C, Martei YM, Narayan VK, Clark AS, Lefebvre B, McDermott K, Koropeckyj-Cox D, Fasan O, Hutsell A, Daniels A, Englefield V, Leger KJ, Getz KD, Narayan HK, Marshall JD, Powell-Wiley TM, Yancy CW, Ky B.   +21 more
europepmc   +1 more source

Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives. [PDF]

Biomolecules
Yücer R, Piccinno R, Ooko E, Dawood M, Bringmann G, Efferth T.   +5 more
europepmc   +1 more source

SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial. [PDF]

Cardiooncology
Greco A, Quagliariello V, Rizzo G, Tedeschi A, Schirinzi S, Turco A, Galiazzo M, Acquaro M, De Amicis M, Klersy C, Ghio S, Perrone L, Paccone A, Uccello G, Canale ML, Oliva S, Guerra F, De Luca L, Maurea N, Scelsi L.   +19 more
europepmc   +1 more source

Anthracycline selection in drug-eluting-beads-transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma: emerging evidence for idarubicin. [PDF]

Hepatobiliary Surg Nutr
Makary MS.
europepmc   +1 more source